CLINICAL_TRIALS
trial_result
· 2013-09-25
Clinical Trial Update: A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Summary
Phase 1 study of dasatinib with concurrent chemoradiation for stage III non-small cell lung cancer was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brown University | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2013-09-25